10-Q · May 7, 2026
Enovis Corporation's Q1 2026 results showed revenue of $589 million, which exceeded the consensus estimate by 3%. Gross profit improved to $365.5 million, pushing the gross margin to 62%. However, the company reported a…
Earnings analysis · 10-Q
Filed November 5, 2026 · Our reading of the company's report
The latest report
The quarter included reported revenue of $558.725 million and adjusted EPS of $0.88, ahead of the supplied consensus estimates of $556.845 million and $0.74, respectively. The 10-Q highlights meaningful international…
The quarter included reported revenue of $558.725 million and adjusted EPS of $0.88, ahead of the supplied consensus estimates of $556.845 million and $0.74, respectively. The 10-Q highlights meaningful international exposure, with 41% of quarterly sales generated outside the United States, and continued sensitivity to variable-rate debt and foreign-exchange movements. Management reported effective disclosure controls and no material changes to the risk factors from the 2025 Form 10-K; the extracted 10-Q text does not provide separate quantitative guidance.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Approximately 41% of sales in the three months ended October 2, 2026 and 44% in the nine months ended October 2, 2026 came from operations outside the United States, highlighting the company’s broad international footprint.
The company reported a $12.7 million gain when forward currency contracts matured on July 2, 2026, in conjunction with settlement of intercompany loan balances.
Management concluded that disclosure controls were effective as of October 2, 2026, and reported no changes in internal control over financial reporting that materially affected, or were reasonably likely to materially affect, controls during the period.
A hypothetical 1% increase in interest rates would have increased interest expense by approximately $2.1 million for the quarter and $6.5 million for the nine months ended October 2, 2026. A significant amount of borrowings is variable-rate debt tied to SOFR.
The company had approximately $130.1 million and $150.1 million of new forward currency contracts maturing April 15, 2027. A portion of cross-currency swaps remains undesignated, which could cause fair-value changes to flow through non-operating income or expense.
The 10-Q states there were no material changes to the risk factors in the 2025 Form 10-K; however, the filing continues to identify foreign-exchange exposure across operations representing 41% of quarterly sales and 44% of year-to-date sales.
The supplied 10-Q excerpt does not include quantitative revenue or EPS guidance. Numeric full-year outlook was provided in the accompanying November 5, 2026 earnings release rather than the extracted 10-Q text.
Enovis Corporation's Q1 2026 results showed revenue of $589 million, which exceeded the consensus estimate by 3%. Gross profit improved to $365.5 million, pushing the gross margin to 62%. However, the company reported a…
Enovis Corporation reported a revenue of $2.248 billion for the year ended December 31, 2025, reflecting a 6.7% increase from the previous year. The company faced operating losses of approximately $1.124 billion,…
Enovis Corporation reported Q3 2025 results showing stronger-than-expected revenue and EPS, significantly surpassing consensus estimates. Although gross margins improved, the company incurred substantial goodwill…
Enovis Corporation reported its Q2 2025 results showing a significant increase in revenue and EPS compared to both the prior quarter and the same quarter last year. Notably, revenue reached $565 million, a 7.6% increase…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.